Core Viewpoint - Acadia Healthcare Company, Inc. is a prominent provider in the inpatient behavioral health care sector, focusing on delivering quality services while aiming for financial growth [1] Financial Performance - In Q4 2025, Acadia reported adjusted earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of $0.03 per share, resulting in an earnings surprise of over 164% [2][6] - Despite the earnings surprise, the company's profit declined by 89% year-over-year, while total revenues reached $821.5 million, reflecting a 6.1% increase compared to the previous year, surpassing the expected $799 million [3][6] - The revenue growth was attributed to a 3.1% increase in patient days and a 2.5% rise in admissions, leading to a 4.4% increase in same-facility revenues [3] Future Projections - Acadia anticipates revenues for 2026 to be between $3.37 billion and $3.45 billion, with adjusted EBITDA projected to range from $575 million to $610 million [4][6] - The company's projections indicate a strategic focus on service expansion and operational efficiency optimization, despite challenges such as a decrease in average length of stay and rising expenses [4] Stock Performance - Currently, ACHC's stock price is $21.48, reflecting a 3.09% increase, with fluctuations between a low of $20.88 and a high of $22.27 during the trading day [5] - Over the past year, the stock has seen a high of $42.85 and a low of $11.43, with a market capitalization of approximately $1.94 billion [5]

Core Viewpoint - Acadia Healthcare is a leading provider in the inpatient behavioral health care sector, recognized for its strong performance and unique market position [1]. Financial Performance - In the fourth quarter, Acadia reported adjusted earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of $0.03, resulting in an earnings surprise of +164.15%. This is a decrease from $0.64 per share in the same quarter last year, but the company has consistently surpassed consensus EPS estimates over the last four quarters [3]. - Total revenues for the quarter reached $821.5 million, surpassing the expected $799 million, marking a 6.1% year-over-year increase driven by higher patient days and admissions, as well as increased revenues per patient day. However, this growth was partially offset by a shorter average length of stay and increased expenses [4]. Future Outlook - Acadia anticipates 2026 revenues to be between $3.37 billion and $3.45 billion, with adjusted EBITDA projected to range from $575 million to $610 million [5][6]. - Following the announcement of its fourth-quarter and full-year 2025 results, Acadia's stock experienced a 23% surge, benefiting from a broader market upswing, with a market capitalization of approximately $2 billion [5]. Analyst Ratings - Raymond James maintained an "Outperform" rating for Acadia Healthcare, indicating confidence in the company's future performance despite a recommendation to "hold" the stock [2][6].

Core Viewpoint - Acadia Healthcare (ACHC) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending September 2025, with the actual results being a significant factor influencing its near-term stock price [1][2]. Earnings Expectations - The upcoming earnings report is scheduled for November 5, and if the results exceed expectations, the stock may rise; conversely, a miss could lead to a decline [2]. - The consensus estimate for quarterly earnings is $0.72 per share, reflecting a year-over-year decrease of 20.9%, while revenues are projected to be $853.31 million, representing a 4.6% increase from the previous year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised 1.73% higher, indicating a collective reassessment by analysts [4]. - The Most Accurate Estimate for Acadia Healthcare is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -9.79%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the deviation of actual earnings from consensus estimates, with positive readings being more reliable [9][10]. - Acadia Healthcare currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, Acadia Healthcare was expected to post earnings of $0.71 per share but achieved $0.83, resulting in a surprise of +16.90% [13]. - Over the past four quarters, the company has exceeded consensus EPS estimates three times [14]. Conclusion - Acadia Healthcare does not appear to be a strong candidate for an earnings beat, and investors should consider additional factors when making decisions regarding the stock ahead of the earnings release [17].

Financial Data and Key Metrics Changes - First quarter revenue for 2025 was $770.5 million, slightly above the midpoint of the guidance range of $765 million to $775 million [5][14] - Adjusted EBITDA for the first quarter was $134.2 million, near the high end of the guidance range of $130 million to $135 million, reflecting an adjusted EBITDA margin of 17.4% [5][15] - Same facility patient days grew by 2.2% in the first quarter, with same facility revenue growth of 2.1% compared to the first quarter of 2024 [5][14] Business Line Data and Key Metrics Changes - The company added 378 new beds in the first quarter, including 90 beds to existing facilities and 288 beds from two new facilities [6] - Same facility adjusted EBITDA was $191.6 million, with an adjusted EBITDA margin of 25.2% [16] - Start-up losses related to new facilities were higher year-over-year and sequentially, reflecting an increase in newly constructed facilities [15] Market Data and Key Metrics Changes - The company expects to add between 800 to 1,000 total beds for the full year 2025, with a solid pipeline of potential opportunities in attractive markets [7][18] - The company anticipates Medicaid supplemental payments to be flat to up $15 million in 2025 on a net basis [19] Company Strategy and Development Direction - Acadia's strategy focuses on high-quality care and clinical health outcomes, with a commitment to quality and safety as foundational elements [10][12] - The company aims to bridge the gap between physical and behavioral health care, maintaining strong relationships with referral sources and joint venture partners [6] - The company is engaged in policy advocacy to strengthen the behavioral health care system, emphasizing the importance of government support for underserved populations [12] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the demand for behavioral health services, particularly for higher acuity patients, and noted consistent demand across various lines of business [38] - The company acknowledged challenges from underperforming facilities but expects to see improvements as they comp over headwinds in the fourth quarter of 2025 [19] - Management remains cautious about rate growth due to uncertainties in the policy environment but noted stable underlying rate growth [35] Other Important Information - As of March 31, 2025, the company had $91.2 million in cash and cash equivalents and approximately $900 million available under its revolving credit facility [18] - The company repurchased approximately 1.6 million shares during the first quarter for a total of $47.3 million [18] Q&A Session Summary Question: Can you provide perspective on the progression of EBITDA and seasonality this year? - Management highlighted several moving parts affecting Q1, including the timing of supplemental payments and the highest level of start-up costs, leading to a steeper ramp in EBITDA as the year progresses [25][28] Question: What are you seeing in Medicaid rate updates? - Management noted ongoing positive discussions with payer partners and maintained a conservative outlook on rate growth due to policy uncertainties, but underlying rate growth has been stable [33][35] Question: How is the broader demand environment for behavioral health? - Management indicated consistent demand for higher acuity patients across various business lines, with ongoing efforts to meet that demand through new facilities and bed additions [38] Question: What is the expected return target for new facilities? - The company applies a disciplined approach to capital deployment, ensuring that all projects meet required return thresholds, with sensitivity analyses incorporated for future projects [63][66] Question: How should we think about legal expenses moving forward? - Management is actively cooperating with ongoing investigations and anticipates that legal costs may normalize as preliminary work is completed [70][72] Question: What is happening with specialty revenue? - Management acknowledged that closures of specialty facilities have contributed to a decline in specialty revenue, but they are working to stabilize and grow this line moving forward [97][98]